Pakistani Pharma Firm Becomes First PIC/S-Recognised Company for Injectables

A Pakistani pharmaceutical company has become the first in the country to receive recognition from the Pharmaceutical Inspection Co-operation Scheme, known as PIC/S, specifically for the manufacture of injections and eye drops. The milestone represents a significant quality benchmark for Pakistan's pharmaceutical sector, which has long sought to align its manufacturing standards with leading global regulatory frameworks.

PIC/S is an international non-binding cooperative arrangement between regulatory authorities that sets globally recognised standards for Good Manufacturing Practice in pharmaceutical production. Recognition by PIC/S signals that a facility's inspection and quality assurance processes meet the benchmarks accepted by major international drug regulators, including those of the European Union, the United States, and Australia.

The development carries meaningful implications for Pakistan's pharmaceutical export capacity. Sterile products such as injectables and ophthalmic preparations are among the most technically demanding to manufacture and regulate, and PIC/S recognition in these categories opens pathways to markets that previously required separate bilateral regulatory clearances.

Industry analysts regard the recognition as a potential catalyst for wider sector upgrades, as competing manufacturers face commercial pressure to meet comparable standards. Pakistan's pharmaceutical industry has been working to expand its export footprint, and institutional recognition of this kind strengthens its credibility with foreign health authorities and procurement bodies.